Altogether, our data unravel a new role for G0S2 in regulating myeloid differentiation and TKI response in CML, and suggest that restoring G0S2 may have clinical utility. The gene discussed is G0S2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.